Radioactive injection targets Hard-to-Treat breast cancer in early trial
Disease control
Recruiting now
This early-phase trial is testing a radioactive drug called 225Ac-TR2205 in 15 women with advanced triple-negative breast cancer that has spread. The main goal is to see if the drug is safe and tolerable, and to measure how much radiation reaches tumors. It is too early to know i…
Phase: EARLY_PHASE1 • Sponsor: Xiaorong Sun • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC